Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry.

Horner S, Niederkorn K, Gattringer T, Furtner M, Topakian R, Lang W, Maier R, Gamillscheg A, Fazekas F.

J Neurol. 2013 Jan;260(1):260-7. doi: 10.1007/s00415-012-6629-9. Epub 2012 Aug 5.

PMID:
22865239
2.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

3.

Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.

Bissessor N, Wong AW, Hourigan LA, Jayasinghe RS, Scalia GS, Burstow DJ, Griffiths LR, Savage M, Walters DL.

Cardiovasc Revasc Med. 2011 May-Jun;12(3):164-9. doi: 10.1016/j.carrev.2010.06.001. Epub 2010 Oct 20.

PMID:
21640934
4.

Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.

Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W; FORI (Foramen Ovale Registro Italiano) Investigators.

Cerebrovasc Dis. 2011;31(2):109-16. doi: 10.1159/000321334. Epub 2010 Nov 17.

PMID:
21088390
5.

Paradoxical brain embolism in a young man: is it only a patent foramen ovale?

Wozniak L, Mielczarek M, Sabiniewicz R.

Neurol Neurochir Pol. 2015;49(1):61-4. doi: 10.1016/j.pjnns.2014.12.003. Epub 2014 Dec 17.

PMID:
25666776
6.

Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism.

Ozdemir AO, Tamayo A, Munoz C, Dias B, Spence JD.

J Neurol Sci. 2008 Dec 15;275(1-2):121-7. doi: 10.1016/j.jns.2008.08.018. Epub 2008 Sep 26.

PMID:
18822432
7.

Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.

Varma C, Benson LN, Warr MR, Yeo E, Yip J, Jaigobin CS, Webb G, McLaughlin PR.

Catheter Cardiovasc Interv. 2004 Aug;62(4):519-25.

PMID:
15274165
8.

Patent foramen ovale and unexplained ischemic cerebrovascular events in children.

Benedik MP, Zaletel M, Meglic NP, Podnar T.

Catheter Cardiovasc Interv. 2007 Dec 1;70(7):999-1007.

PMID:
18044736
9.

Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.

Białkowski J, Wawrzyńczyk M, Karwot B, Fiszer R, Knop M, Szkutnik M.

Kardiol Pol. 2012;70(11):1142-6.

10.

Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.

Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.

Catheter Cardiovasc Interv. 2017 Jan;89(1):124-133. doi: 10.1002/ccd.26518. Epub 2016 Mar 29.

PMID:
27027873
11.

Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study.

Rigatelli G, Dell'avvocata F, Braggion G, Giordan M, Chinaglia M, Cardaioli P.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):973-6. doi: 10.1002/ccd.21761.

PMID:
19021284
12.

Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.

Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L; CLOSURE I Investigators.

Stroke. 2010 Dec;41(12):2872-83. doi: 10.1161/STROKEAHA.110.593376. Epub 2010 Nov 4.

13.

Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.

Mirzaali M, Dooley M, Wynne D, Cooter N, Lee L, Haworth P, Saha R, Gainsborough N, Hildick-Smith D.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1078-84. doi: 10.1002/ccd.26080. Epub 2015 Jun 23.

PMID:
26105198
14.

Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events.

Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, Puga FJ, Orszulak TA, Anderson BJ, Brown RD Jr, Schaff HV.

Circulation. 1999 Nov 9;100(19 Suppl):II171-5.

15.

Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.

Wawrzyńczyk M, Gałeczka M, Karwot B, Knop M, Białkowski J.

Kardiol Pol. 2016;74(4):385-9. doi: 10.5603/KP.a2015.0194. Epub 2015 Sep 28.

16.

Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.

Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.

Am J Cardiol. 2008 May 15;101(10):1487-92. doi: 10.1016/j.amjcard.2008.01.028. Epub 2008 Mar 17.

PMID:
18471463
17.

Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.

Spies C, Khandelwal A, Timmemanns I, Kavinsky CJ, Schräder R, Hijazi ZM.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):966-70. doi: 10.1002/ccd.21737.

PMID:
18942060
18.

Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.

Luermans JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, Chessa M, Onorato E, Goy JJ, Budts WI.

Catheter Cardiovasc Interv. 2008 May 1;71(6):822-8. doi: 10.1002/ccd.21458.

PMID:
18324695
19.

Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.

Ford MA, Reeder GS, Lennon RJ, Brown RD, Petty GW, Cabalka AK, Cetta F, Hagler DJ.

JACC Cardiovasc Interv. 2009 May;2(5):404-11. doi: 10.1016/j.jcin.2008.12.015.

20.

Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years.

Fischer D, Gardiwal A, Haentjes J, Klein G, Meyer GP, Drexler H, Hausmann D, Schaefer A.

Clin Res Cardiol. 2012 Apr;101(4):297-303. doi: 10.1007/s00392-011-0392-2. Epub 2011 Dec 10.

PMID:
22159895

Supplemental Content

Support Center